Civica Inc. to Expand in Greater Richmond- Petersburg Region, Investing $27.8 Million for a New Testing Facility

Governor Glenn Youngkin today announced that non-profit Civica Inc. (Civica) will invest $27.8 million to establish a new laboratory testing facility at Meadowville Technology Park in Chesterfield County. The company will construct a 55,000-square-foot facility to support Civica’s Petersburg pharmaceutical manufacturing operation through quality testing and development of new products. The project will create 51 new...

National Essential Medicine Shortage Awareness Day

On this National Essential Medicine Shortage Awareness Day, September 8, we redouble our commitment to make quality essential medicines available and affordable to everyone. The shortage of medicines – including those used in emergency room care, the ICU, pain management, blood pressure control, and sedation – means unstable supplies for patient care and unpredictable...

CivicaScript Announces Launch of its First Product, Creating Significant Patient Savings

CivicaScript, a public benefit company dedicated to bringing lower-cost generic medicines to U.S. consumers, today announced the availability of its first product: abiraterone acetate 250 mg tablets. Abiraterone is used together with steroid medication (prednisone) to treat prostate cancer that has spread to other parts of the body. Starting today, CivicaScript will offer abiraterone...

Navitus Health Solutions Joins CivicaScript to Further Availability of Lower-Cost Generic Medications

Navitus Health Solutions, an industry-disrupting pharmacy benefit manager (PBM) committed to bringing humanity to pharmacy benefits management through greater transparency and affordability, and CivicaScript, a statutory public benefit company dedicated to bringing lower-cost generic medicines to U.S. consumers, announced today that Navitus has joined CivicaScript as a founding member. This new partnership will enable...

Civica Joins the End Drug Shortages Alliance

Civica, Inc. (Civica Rx) announced today it has joined a new coalition of diverse stakeholders to address drug shortages in the United States. The End Drug Shortages Alliance provides a forum for key stakeholders to take strategic aim at one of health care’s more pressing and enduring issues, drug shortages that disrupt patient care....

EmsanaRx Joins CivicaScript to Make Lower-Cost Generic Medicines Available to its Pharmacy Benefit Members

CivicaScript, which is dedicated to bringing lower-cost generic medicines to U.S. consumers, and EmsanaRx, PBC, the only pharmacy benefit manager built by employers, for employers, announced today that EmsanaRx is joining CivicaScript as a partnering member. The partnership will make CivicaScript medicines available to EmsanaRx’s self-funded employer members. “We welcome the partnership of EmsanaRx as...

Civica Announces Leadership Transition

Civica, Inc. announces that Ned McCoy, currently Civica’s Chief Operating Officer, will succeed Martin VanTrieste as Civica’s President and Chief Executive Officer, effective June 1. VanTrieste will remain an advisor to the Company and continue serving on Civica’s Board of Directors. As part of this transition, McCoy will also join the Civica Board of...

Civica Applauds U.S. Legislation to Shift from Paper to Electronic Prescribing Information

I am writing in support of the H.R. 7559, the Prescription Information Modernization Act, which would allow provision of prescribing information in an electronic format, instead of on paper. Civica is a non-profit generic drug company established by U.S. health systems and three philanthropic organizations to reduce chronic drug shortages and ensure a safe...

Civica to Manufacture and Distribute Affordable Insulin

Civica Rx today announced plans to manufacture and distribute insulins that, once approved, will be available to people with diabetes at significantly lower prices than insulins currently on the market. The availability of affordable insulins will benefit people with diabetes who have been forced to choose between life sustaining medicines and living expenses, particularly...

Scroll to top